MIRENA système intra-utérin SIU

7680529960158 CH-52996 G02BA03 09.02.2.

Active substances:

MIRENA système intra-utérin SIU
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
5299601
CPT
-
Packaging group
1
Unit
Stück
Composition
levonorgestrelum 52 mg cum liberatione 20 µg/24 h, poly(dimethylsiloxani) elastomerum, silica colloidalis anhydrica, polyethylenum, barii sulfas, E 172 (nigrum) pro praeparatione.

Articles (1)

Mirena, Intrauterines Wirkstofffreisetzungssystem
Intrauterines Wirkstofffreisetzungssystem
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
29/11/2023
Patient information leaflet
Français
29/11/2023
Patient information leaflet
Italien
29/11/2023
Professional SmPC
Allemand
29/11/2023
Professional SmPC
Français
29/11/2023
Professional SmPC
Italien
29/11/2023

Detailed composition

Substance Quantity Type Category
levonorgestrelum
52.0 MG Substance Wirkstoff (Principe actif)
poly(dimethylsiloxani) elastomerum
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
polyethylenum
- Substance HNIDK
barii sulfas
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK

Authorization holder

Bayer (Schweiz) AG

8045 Zürich

Authorization information

Swissmedic authorization number
52996
Drug name
Mirena, Intrauterines Wirkstofffreisetzungssystem
Galenic form
IUWFS
ATC Code
G02BA03
Authorization status
Z
Dispensation category
B
First authorization
28/07/1995
Authorization expiration date
31/12/9999
IT number
09.02.2.
Domain
Human medicine
Field of application
Intrauterine Kontrazeption / Idiopathische Hypermenorrhoe / Schutz vor Endometriumshyperplasie bei Östrogensubstitution

Packaging details

Description (FR)
MIRENA système intra-utérin SIU
Description (DE)
MIRENA Intrauterinsystem IUP
Market launch
28/07/1995
Narcotic (BTM)
No
Buy us a coffee Explore the data